The amino terminal lectin-like domain of thrombomodulin is required for constitutive endocytosis

Blood

Volumn 89, Issue 2, 1997, Pages 652-661

  Conway, Edward M ^a   Pollefeyt, Saskia ^b   Collen, Desiré ^b   Steiner Mosonyi, Marta ^b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; LECTIN; MUTANT PROTEIN; PROTEIN C; SIGNAL PEPTIDE; THROMBIN; THROMBOMODULIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CELL LINE; ELECTRON MICROSCOPY; ENDOCYTOSIS; ENZYME ACTIVATION; IMMUNOFLUORESCENCE; INTERNALIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN STRUCTURE; PROTEIN TRANSPORT;

EID: 0031023957     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.2.652     Document Type: Article

References (63)

1. Esmon CT: The regulation of natural anticoagulant pathways. Science 235:1348, 1987
2. Esmon C: Thrombomodulin as a model of molecular mechanisms that modulate protease specificity and function at the vessel surface. FASEB J 9:946, 1995
3. Bovill EG, Bauer KA, Dickerman JD, Callas P, West B: The clinical spectrum of heterozygous protein C deficiency in a large New England kindred. Blood 73:712, 1989
4. Seligsohn U, Berger A, Abend M, Rubin L, Attias D, Zivelin A, Rapaport SI: Homozygous protein C deficiency manifested by massive venous thrombosis in the newborn. N Engl J Med 310:559, 1984
5. Ohlin A-K, Marlar R: The first mutation identified in the thrombomodulin gene in a 45 year old man presenting with thromboembolic disease. Blood 85:330, 1995
6. Jackman RW, Beeler DL, Fritze L, Soff G, Rosenberg RD: Human thrombomodulin gene is intron depleted: Nucleic acid sequences of the cDNA and gene predict protein structure and suggest sites of regulatory control. Proc Natl Acad Sci USA 84:6425, 1987
7. Kurosawa S, Stearns DJ, Jackson KW, Esmon CT: A 10-kDa cyanogen bromide fragment from the epidermal growth factor homology domain of rabbit thrombomodulin contains the primary thrombin binding site. J Biol Chem 263:5993, 1988
8. Suzuki K, Hayashi T, Nishioka J, Kosaka Y, Zushi M, Honda G, Yamamoto S: A domain composed of epidermal growth factor-like structures of human thrombomodulin is essential for thrombin binding and for protein C activation. J Biol Chem 264:4872, 1989
9. Zushi M, Gomi K, Yamamoto S, Maruyama I, Hayashi T, Suzuki K: The last three consecutive epidermal growth factor-like structures of human thrombomodulin comprise the minimum functional domain for protein C-activating cofactor activity and anticoagulant activity. J Biol Chem 264:10351, 1989
10. Suzuki K, Kusomoto H, Deyashiki Y, Hishioka J, Maruyama I, Zushi M, Kawahara S, Honda G, Yamamoto S, Horiguchi S: Structure and expression of human thrombomodulin, a thrombin receptor on endothelium acting as a cofactor for protein C activation. EMBO J 6:1891, 1987
11. Wen D, Dittman WA, Ye RD, Deaven LL, Majerus PW, Sadler JE: Human thrombomodulin: Complete cDNA sequence and chromosome localization of the gene. Biochemistry 26:4350, 1987
12. Petersen T: The amino-terminal domain of thrombomodulin and pancreatic stone protein are homologous with lectins. FEBS Lett 231:51, 1988
13. Patthy L: Detecting distant homologies of mosaic proteins. Analysis of the sequences of thrombomodulin, thrombospondin, complement components C9, C8 alpha and C8 beta, vitronectin and plasma cell membrane glycoprotein PC-1. J Mol Biol 202:689, 1988
14. McEver R: Leukocyte interactions mediated by selectins. Thromb Haemost 66:80, 1991
15. Lu R, Esmon NL, Esmon CT, Johnson AE: The active site of the thrombin-thrombomodulin complex. J Biol Chem 264:12956, 1989
16. Conway E, Nowakowski B, Steiner-Mosonyi M: Thrombomodulin lacking the cytoplasmic domain efficiently internalizes thrombin via nonclathrin-coated, pit-mediated endocytosis. J Cell Physiol 158:285, 1994
17. Conway E, Boffa M, Nowakowski B, Steiner-Mosonyi M: An ultrastructural study of thrombomodulin endocytosis: Internalization occurs via clathrin-coated and non-coated pits. J Cell Physiol 151:604, 1992
18. Conway EM, Lau HK, Bauer KA, Rosenberg RD: Development of a radioimmunoassay for quantitating prethrombin 2 in human plasma. J Lab Clin Med 110:567, 1987
19. Yu K, Morioka H, Fritze L, Beeler D, Jackman R, Rosenberg R: Transcriptional regulation of the thrombomodulin gene. J Biol Chem 267:23237, 1992
20. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-pheno-chloroform extraction. Anal Biochem 162:156, 1987
21. Conway E, Nowakowski B: Biologically active thrombomodulin is synthesized by adherent synovial fluid cells and is elevated in synovial fluid of patients with rheumatoid arthritis. Blood 81:726, 1993
22. Feinberg AP, Vogelstein B: A technique for radiolabelling DNA restriction endouclease fragments to high specific activity. Anal Biochem 132:6, 1983
23. Frens G: Controlled nucleation for the regulation of the particle size in monodisperse gold suspensions. Nat Phys Sci 241:20, 1973
24. Liu CY, Handley DA, Chien S: Gold labeling of thrombin and ultrastructural studies of thrombin-gold conjugate binding by fibrin. Anal Biochem 147:49, 1985
25. Horisberger M: Evaluation of colloidal gold as a cytochemical marker for transmission and scanning electron microscopy. Biol Cell 36:253, 1979
26. Zar J: Biostatistical Analysis. Englewood Cliffs, NJ, Prentice Hall, 1974
27. Fallon RJ, Schwartz AL: Asialoglycoprotein receptor phosphorylation and receptor-mediated endocytosis in hepatoma cells. J Biol Chem 263:13159, 1988
28. Schneider C, Owen M, Banville D, Williams J: Primary structure of human transferrin receptor deduced from the mRNA sequence. Nature 311:675, 1984
29. Leytus S, Loegb K, Hagen F, Kurachi K, Davie E: A novel trypsin-like serine protease (hepsin) with a putative transmembrane domain expressed by human liver and hepatoma cells. Biochemistry 27:1067, 1988
30. Altieri D: Molecular cloning of effector cell protease receptor-1, a novel cell surface receptor for the protease factor Xa. J Biol Chem 269:3139, 1994
31. Hirokawa K, Aoki N: Regulatory mechanisms for thrombomodulin expression in human umbilical vein endothelial cells in vitro. J Cell Physiol 147:157, 1991
32. Beretz A, Freysinnet J-M, Gauchy J, Schmitt DA, Klein-Soyer C, Edgell C-JS, Cazenave J-P: Stability of the thrombin-thrombomodulin complex on the surface of endothelial cells from human saphenous vein or from the cell line EA.hy 926. Biochem J 259:35, 1989
33. Brisson C, Archipoff G, Harrmann M-L, Hanau D, Beretz A, Freyssinet J-M, Cazenave J-P: Antibodies to thrombomodulin induce receptor-mediated endocytosis in human saphenous vein endothelial cells. Thromb Haemost 68:737, 1993
34. Maruyama I, Bell C, Majerus P: Thrombomodulin is found on endothelium of arteries, capilalaries, and lymphatics, and on syncytiotrophoblast of human placenta. J Cell Biol 101:363, 1985
35. Maruyama I, Majerus P: Protein C inhibits endocytosis of thrombin-thrombomodulin complexes in A549 lung cancer cells and human umbilical vein endothelial cells. Blood 69:1481, 1987
36. Moore KL, Esmon CT, Esmon NL: Tumor necrosis factor leads to the internalization and degradation of thrombomodulin from the surface of bovine aortic endothelial cells in culture. Blood 73:159, 1989
37. Boffa M, Karochkine M, Berard M: Plasma thrombomodulin as a marker of endothelium damage. Nouv Rev Fr Hematol 33:529, 1991
38. Conway E, Liu L, Nowakowski B, Steiner-Mosonyi M, Jackman R: Heat shock of vascular endothelial cells induces an upregulatory transcriptional response of the thrombomodulin gene that is delayed in onset and does not attenuate. J Biol Chem 269:22804, 1994
39. Kawakami K, Yamamoto K, Toyoshima S, Osawa T, Irimura T: Dual function of macrophage galactose/N-acetylgalactosamine-specific lectins: Glycoprotein uptake and tumoricidal cellular recognition. Jpn J Cancer Res 85:744, 1994
40. Borges D, Kouyoumdjian M: Plasma kallikrein clearance by the liver: A review. Braz J Med Biol Res 27:2033, 1994
41. Krauss J, Poo H, Xue W, Mayo-Bond L, Todd R III, Petty H: Reconstitution of antibody-dependent phagocytosis in fibroblasts expressing Fcγ and the complement receptor type 3. J Immunol 153:1769, 1994
42. Palmer R, Ferrige A, Moncada S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327:524, 1987
43. Prescott S, Zimmerman G, McIntyre T: Human endothelial cells in culture produce platelet-activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when stimulated with thrombin. Proc Natl Acad Sci USA 81:3534, 1984
44. Glusa E: Vascular effects of thrombin. Semin Thromb Hemost 18:296, 1992
45. Li X, Varma V, Parks J, Benza R, Koons J, Grammer J, Grenett H, Tabengwa E, Booyse F: Thrombin decreases the urokinase receptor and surface-localized fibrinolysis in cultured endothelial cells. Arteroscler Thromb Vasc Biol 15:410, 1995
46. Reuning U, Bang N: Regulation of the urokinase-type plasminogen activator receptor on vascular smooth muscle cells is under the control of thrombin and other mitogens. Arteroscler Thromb 12:1161, 1992
47. Chen L, Teng N, Buchanan J: Mitogenicity of thrombin and surface alterations on mouse splenocytes. Exp Cell Res 101:41, 1976
48. Bar-Shavit R, Kahn AJ, Mann KG, Wilner GD: Identification of a thrombin sequence with growth factor activity on macrophages. Proc Natl Acad Sci USA 83:976, 1986
49. Bar-Shavit R, Hruska K, Kahn A, Wilner G: Hormone-like activity of human thrombin. Ann NY Acad Sci 485:335, 1986
50. Tatakis D, Dolce C, Dziak R: Thrombin's effects on osteoblastic cells. I. Cytolosolic calcium and phosphoinositides. Biochem Biophys Res Commun 164:119, 1989
51. Furmaniak-Kazmierczak E, Cooke T, Manuel R, Scudamore A, Hoogendorn H, Giles A, Nesheim M: Studies of thrombin-induced proteoglycan release in the degradation of human and bovine cartilage. J Clin Invest 94:472, 1994
52. Vu TK, Hung DT, Wheaton VI, Coughlin SR: Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64:1057, 1991
53. Woolkalis M, DeMelfi TJ, Blanchard N, Hoxie J, Brass L: Regulation of thrombin receptors on human umbilical vein endothelial cells. J Biol Chem 270:9868, 1995
54. Brass LF, Pizarro S, Ahuja M, Belmonte E, Blanchard N, Stadel JM, Hoxie JA: Changes in the structure and function of the human thrombin receptor during receptor activation, internalization, and recycling. J Biol Chem 269:2943, 1994
55. Connolly A, Ishihara H, Kahn M, Farese R Jr, Coughlin S: Role of the thrombin receptor in development and evidence for a second receptor. Nature 381:516, 1996
56. Raife TJ, Lager DJ, Madison KC, Piette WW, Howard EJ, Sturm MT, Chen Y, Lentz SR: Thrombomodulin expression by human keratinocytes. Induction of cofactor activity during epidermal differentiation. J Clin Invest 93:1846, 1994
57. Conway E, Nowakowski B, Steiner-Mosonyi M: Human neutrophils synthesize thrombomodulin that does not promote thrombin-dependent protein C activation. Blood 80:1254, 1992
58. McCachren SS, Diggs J, Weinberg JB, Dittman WA: Thrombomodulin expression by human blood monocytes and by human synovial tissue lining macrophages. Blood 78:3128, 1991
59. Soff GA, Jackman RW, Rosenberg RD: Expression of thrombomodulin by smooth muscle cells in culture: Different effects of tumor necrosis factor and cyclic adenosine monophosphate on thrombomodulin expression by endothelial cells and smooth muscle cells in culture. Blood 77:515, 1991
60. Weiler-Guettler H, Aird W, Husain M, Rayburn H, Rosenberg R: Targeting of transgene expression to the vascular endothelium of mice by homologous recombination at the thrombomodulin locus. Circ Res 78:180, 1996
61. Imada S, Yamaguchi H, Nagumo M, Katayanagi S, Iwasaki H, Imada M: Identification of fetomodulin, a surface marker protein of fetal development, as thrombomodulin by gene cloning and functional assays. Dev Biol 140:113, 1990
62. Healy A, Rayburn H, Rosenberg R, Weiler H: Absence of the blood-clotting regulator thrombomodulin causes embryonic lethality in mice before development of a functional cardiovascular system. Proc Natl Acad Sci USA 92:850, 1995
63. Mody R, Joshi S, Chaney W: Use of lectins as diagnostic and therapeutic tools for cancer. J Pharmacol Toxicol Methods 33:1, 1995